Global Blood Glucose Device Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 03-Oct-2022
No. of pages: 107
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Blood Glucose Device manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Blood Glucose Device market. Further, it explains the major drivers and regional dynamics of the global Blood Glucose Device market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Abbott Laboratories (U.S.)

- ARKRAY (Japan)

- Dexcom (U.S.)

- F.Hoffmann-La Roche Ltd (Switzerland)

- Johnson & Johnson (U.S.)

- Medtronic (U.S.)

- Nipro Diagnostics (U.S.)

- Terumo Medical Corporation (U.S.)

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Blood Glucose Device Segment by Type

- Blood Glucose Monitors

- Glucose Monitoring Strips

- Lancets

Blood Glucose Device Segment by Application

- Hospitals

- Diagnostics

- Home Settings

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Blood Glucose Device market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Blood Glucose Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Blood Glucose Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Blood Glucose Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Glucose Device sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Blood Glucose Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Blood Glucose Device sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott Laboratories (U.S.), ARKRAY (Japan), Dexcom (U.S.), F.Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (U.S.), Medtronic (U.S.), Nipro Diagnostics (U.S.) and Terumo Medical Corporation (U.S.), etc.

Global Blood Glucose Device Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Blood Glucose Device Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Blood Glucose Monitors
1.2.3 Glucose Monitoring Strips
1.2.4 Lancets
1.3 Market Segment by Application
1.3.1 Global Blood Glucose Device Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Diagnostics
1.3.4 Home Settings
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Blood Glucose Device Market Size (2017-2028)
2.1.1 Global Blood Glucose Device Revenue (2017-2028)
2.1.2 Global Blood Glucose Device Sales (2017-2028)
2.2 Global Blood Glucose Device Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Blood Glucose Device Sales by Regions (2017-2022)
2.2.2 Global Blood Glucose Device Revenue by Regions (2017-2022)
2.3 Global Blood Glucose Device Market Size Forecast by Region
2.3.1 Global Blood Glucose Device Sales Forecast by Region (2023-2028)
2.3.2 Global Blood Glucose Device Revenue Forecast by Region (2023-2028)
2.4 Global Top Blood Glucose Device Regions (Countries) Ranking by Market Size
2.5 Blood Glucose Device Market Dynamics
2.5.1 Blood Glucose Device Market Trends
2.5.2 Blood Glucose Device Market Drivers
2.5.3 Blood Glucose Device Market Challenges
2.5.4 Blood Glucose Device Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Blood Glucose Device Manufacturers by Sales (2017-2022)
3.1.1 Global Blood Glucose Device Sales by Manufacturers (2017-2022)
3.1.2 Global Blood Glucose Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Blood Glucose Device Sales in 2021
3.2 Global Top Manufacturers Blood Glucose Device by Revenue
3.2.1 Global Blood Glucose Device Revenue by Manufacturers (2017-2022)
3.2.2 Top Blood Glucose Device Manufacturers Covered: Ranking by Revenue
3.2.3 Global Blood Glucose Device Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Blood Glucose Device Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Glucose Device as of 2021)
3.4 Global Blood Glucose Device Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Blood Glucose Device Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Blood Glucose Device Market
3.7 Key Manufacturers Blood Glucose Device Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Blood Glucose Device Market Size by Type
4.1 Global Blood Glucose Device Historic Market Review by Type (2017-2022)
4.1.1 Global Blood Glucose Device Sales Market Share by Type (2017-2022)
4.1.2 Global Blood Glucose Device Revenue Market Share by Type (2017-2022)
4.1.3 Blood Glucose Device Price by Type (2017-2022)
4.2 Global Blood Glucose Device Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Blood Glucose Device Sales Forecast by Type (2023-2028)
4.2.2 Global Blood Glucose Device Revenue Forecast by Type (2023-2028)
4.2.3 Blood Glucose Device Price Forecast by Type (2023-2028)
5 Global Blood Glucose Device Market Size by Application
5.1 Global Blood Glucose Device Historic Market Review by Application (2017-2022)
5.1.1 Global Blood Glucose Device Sales Market Share by Application (2017-2022)
5.1.2 Global Blood Glucose Device Revenue Market Share by Application (2017-2022)
5.1.3 Blood Glucose Device Price by Application (2017-2022)
5.2 Global Blood Glucose Device Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Blood Glucose Device Sales Forecast by Application (2023-2028)
5.2.2 Global Blood Glucose Device Revenue Forecast by Application (2023-2028)
5.2.3 Blood Glucose Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Blood Glucose Device Sales Breakdown by Company
6.1.1 North America Blood Glucose Device Sales by Company (2017-2022)
6.1.2 North America Blood Glucose Device Revenue by Company (2017-2022)
6.2 North America Blood Glucose Device Market Size by Type
6.2.1 North America Blood Glucose Device Sales by Type (2017-2028)
6.2.2 North America Blood Glucose Device Revenue by Type (2017-2028)
6.3 North America Blood Glucose Device Market Size by Application
6.3.1 North America Blood Glucose Device Sales by Application (2017-2028)
6.3.2 North America Blood Glucose Device Revenue by Application (2017-2028)
6.4 North America Blood Glucose Device Market Size by Country
6.4.1 North America Blood Glucose Device Sales by Country (2017-2028)
6.4.2 North America Blood Glucose Device Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Blood Glucose Device Sales Breakdown by Company
7.1.1 Europe Blood Glucose Device Sales by Company (2017-2022)
7.1.2 Europe Blood Glucose Device Revenue by Company (2017-2022)
7.2 Europe Blood Glucose Device Market Size by Type
7.2.1 Europe Blood Glucose Device Sales by Type (2017-2028)
7.2.2 Europe Blood Glucose Device Revenue by Type (2017-2028)
7.3 Europe Blood Glucose Device Market Size by Application
7.3.1 Europe Blood Glucose Device Sales by Application (2017-2028)
7.3.2 Europe Blood Glucose Device Revenue by Application (2017-2028)
7.4 Europe Blood Glucose Device Market Size by Country
7.4.1 Europe Blood Glucose Device Sales by Country (2017-2028)
7.4.2 Europe Blood Glucose Device Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Blood Glucose Device Sales Breakdown by Company
8.1.1 Asia Pacific Blood Glucose Device Sales by Company (2017-2022)
8.1.2 Asia Pacific Blood Glucose Device Revenue by Company (2017-2022)
8.2 Asia Pacific Blood Glucose Device Market Size by Type
8.2.1 Asia Pacific Blood Glucose Device Sales by Type (2017-2028)
8.2.2 Asia Pacific Blood Glucose Device Revenue by Type (2017-2028)
8.3 Asia Pacific Blood Glucose Device Market Size by Application
8.3.1 Asia Pacific Blood Glucose Device Sales by Application (2017-2028)
8.3.2 Asia Pacific Blood Glucose Device Revenue by Application (2017-2028)
8.4 Asia Pacific Blood Glucose Device Market Size by Region
8.4.1 Asia Pacific Blood Glucose Device Sales by Region
8.4.2 Asia Pacific Blood Glucose Device Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Blood Glucose Device Sales Breakdown by Company
9.1.1 Latin America Blood Glucose Device Sales by Company (2017-2022)
9.1.2 Latin America Blood Glucose Device Revenue by Company (2017-2022)
9.2 Latin America Blood Glucose Device Market Size by Type
9.2.1 Latin America Blood Glucose Device Sales by Type (2017-2028)
9.2.2 Latin America Blood Glucose Device Revenue by Type (2017-2028)
9.3 Latin America Blood Glucose Device Market Size by Application
9.3.1 Latin America Blood Glucose Device Sales by Application (2017-2028)
9.3.2 Latin America Blood Glucose Device Revenue by Application (2017-2028)
9.4 Latin America Blood Glucose Device Market Size by Country
9.4.1 Latin America Blood Glucose Device Sales by Country (2017-2028)
9.4.2 Latin America Blood Glucose Device Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Blood Glucose Device Sales Breakdown by Company
10.1.1 Middle East and Africa Blood Glucose Device Sales by Company (2017-2022)
10.1.2 Middle East and Africa Blood Glucose Device Revenue by Company (2017-2022)
10.2 Middle East and Africa Blood Glucose Device Market Size by Type
10.2.1 Middle East and Africa Blood Glucose Device Sales by Type (2017-2028)
10.2.2 Middle East and Africa Blood Glucose Device Revenue by Type (2017-2028)
10.3 Middle East and Africa Blood Glucose Device Market Size by Application
10.3.1 Middle East and Africa Blood Glucose Device Sales by Application (2017-2028)
10.3.2 Middle East and Africa Blood Glucose Device Revenue by Application (2017-2028)
10.4 Middle East and Africa Blood Glucose Device Market Size by Country
10.4.1 Middle East and Africa Blood Glucose Device Sales by Country (2017-2028)
10.4.2 Middle East and Africa Blood Glucose Device Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Abbott Laboratories (U.S.)
11.1.1 Abbott Laboratories (U.S.) Corporation Information
11.1.2 Abbott Laboratories (U.S.) Overview
11.1.3 Abbott Laboratories (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories (U.S.) Blood Glucose Device Products and Services
11.1.5 Abbott Laboratories (U.S.) Blood Glucose Device SWOT Analysis
11.1.6 Abbott Laboratories (U.S.) Recent Developments
11.2 ARKRAY (Japan)
11.2.1 ARKRAY (Japan) Corporation Information
11.2.2 ARKRAY (Japan) Overview
11.2.3 ARKRAY (Japan) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 ARKRAY (Japan) Blood Glucose Device Products and Services
11.2.5 ARKRAY (Japan) Blood Glucose Device SWOT Analysis
11.2.6 ARKRAY (Japan) Recent Developments
11.3 Dexcom (U.S.)
11.3.1 Dexcom (U.S.) Corporation Information
11.3.2 Dexcom (U.S.) Overview
11.3.3 Dexcom (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Dexcom (U.S.) Blood Glucose Device Products and Services
11.3.5 Dexcom (U.S.) Blood Glucose Device SWOT Analysis
11.3.6 Dexcom (U.S.) Recent Developments
11.4 F.Hoffmann-La Roche Ltd (Switzerland)
11.4.1 F.Hoffmann-La Roche Ltd (Switzerland) Corporation Information
11.4.2 F.Hoffmann-La Roche Ltd (Switzerland) Overview
11.4.3 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Products and Services
11.4.5 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device SWOT Analysis
11.4.6 F.Hoffmann-La Roche Ltd (Switzerland) Recent Developments
11.5 Johnson & Johnson (U.S.)
11.5.1 Johnson & Johnson (U.S.) Corporation Information
11.5.2 Johnson & Johnson (U.S.) Overview
11.5.3 Johnson & Johnson (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson (U.S.) Blood Glucose Device Products and Services
11.5.5 Johnson & Johnson (U.S.) Blood Glucose Device SWOT Analysis
11.5.6 Johnson & Johnson (U.S.) Recent Developments
11.6 Medtronic (U.S.)
11.6.1 Medtronic (U.S.) Corporation Information
11.6.2 Medtronic (U.S.) Overview
11.6.3 Medtronic (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Medtronic (U.S.) Blood Glucose Device Products and Services
11.6.5 Medtronic (U.S.) Blood Glucose Device SWOT Analysis
11.6.6 Medtronic (U.S.) Recent Developments
11.7 Nipro Diagnostics (U.S.)
11.7.1 Nipro Diagnostics (U.S.) Corporation Information
11.7.2 Nipro Diagnostics (U.S.) Overview
11.7.3 Nipro Diagnostics (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Nipro Diagnostics (U.S.) Blood Glucose Device Products and Services
11.7.5 Nipro Diagnostics (U.S.) Blood Glucose Device SWOT Analysis
11.7.6 Nipro Diagnostics (U.S.) Recent Developments
11.8 Terumo Medical Corporation (U.S.)
11.8.1 Terumo Medical Corporation (U.S.) Corporation Information
11.8.2 Terumo Medical Corporation (U.S.) Overview
11.8.3 Terumo Medical Corporation (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Terumo Medical Corporation (U.S.) Blood Glucose Device Products and Services
11.8.5 Terumo Medical Corporation (U.S.) Blood Glucose Device SWOT Analysis
11.8.6 Terumo Medical Corporation (U.S.) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Blood Glucose Device Value Chain Analysis
12.2 Blood Glucose Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Blood Glucose Device Production Mode & Process
12.4 Blood Glucose Device Sales and Marketing
12.4.1 Blood Glucose Device Sales Channels
12.4.2 Blood Glucose Device Distributors
12.5 Blood Glucose Device Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Blood Glucose Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Blood Glucose Monitors
Table 3. Major Manufacturers of Glucose Monitoring Strips
Table 4. Major Manufacturers of Lancets
Table 5. Global Blood Glucose Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Blood Glucose Device Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Blood Glucose Device Sales by Region (2017-2022) & (K Units)
Table 8. Global Blood Glucose Device Sales Market Share by Region (2017-2022)
Table 9. Global Blood Glucose Device Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Blood Glucose Device Revenue Market Share by Region (2017-2022)
Table 11. Global Blood Glucose Device Sales Forecast by Region (2023-2028) & (K Units)
Table 12. Global Blood Glucose Device Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Blood Glucose Device Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Blood Glucose Device Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Blood Glucose Device Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Blood Glucose Device Market Trends
Table 17. Blood Glucose Device Market Drivers
Table 18. Blood Glucose Device Market Challenges
Table 19. Blood Glucose Device Market Restraints
Table 20. Global Blood Glucose Device Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Blood Glucose Device Sales Share by Manufacturers (2017-2022)
Table 22. Global Blood Glucose Device Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Blood Glucose Device Manufacturers by Revenue (US$ Million) in 2021
Table 24. Blood Glucose Device Revenue Share by Manufacturers (2017-2022)
Table 25. Global Blood Glucose Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Glucose Device as of 2021)
Table 27. Key Manufacturers Blood Glucose Device Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 28. Key Manufacturers Blood Glucose Device Plants/Factories Distribution
Table 29. Key Manufacturers Blood Glucose Device Area Served
Table 30. Date of Key Manufacturers Enter into Blood Glucose Device Market
Table 31. Key Manufacturers Blood Glucose Device Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Blood Glucose Device Sales (K Units) by Type (2017-2022)
Table 34. Global Blood Glucose Device Sales Share by Type (2017-2022)
Table 35. Global Blood Glucose Device Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Blood Glucose Device Price (K Units) by Type (2017-2022)
Table 37. Global Blood Glucose Device Sales (K Units) by Type (2023-2028)
Table 38. Global Blood Glucose Device Sales Share by Type (2023-2028)
Table 39. Global Blood Glucose Device Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Blood Glucose Device Revenue Share by Type (2023-2028)
Table 41. Global Blood Glucose Device Price (K Units) by Type (2023-2028)
Table 42. Global Blood Glucose Device Sales (K Units) by Application (2017-2022)
Table 43. Global Blood Glucose Device Sales Share by Application (2017-2022)
Table 44. Global Blood Glucose Device Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Blood Glucose Device Price (K Units) by Application (2017-2022)
Table 46. Global Blood Glucose Device Sales (K Units) by Application (2023-2028)
Table 47. Global Blood Glucose Device Sales Share by Application (2023-2028)
Table 48. Global Blood Glucose Device Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Blood Glucose Device Revenue Share by Application (2023-2028)
Table 50. Global Blood Glucose Device Price (K Units) by Application (2023-2028)
Table 51. North America Blood Glucose Device Sales by Company (2017-2022) & (K Units)
Table 52. North America Blood Glucose Device Sales Market Share by Company (2017-2022)
Table 53. North America Blood Glucose Device Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Blood Glucose Device Revenue Market Share by Company (2017-2022)
Table 55. North America Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 56. North America Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 57. North America Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 60. North America Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 61. North America Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 64. North America Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 65. North America Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Blood Glucose Device Sales by Company (2017-2022) & (K Units)
Table 68. Europe Blood Glucose Device Sales Market Share by Company (2017-2022)
Table 69. Europe Blood Glucose Device Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Blood Glucose Device Revenue Market Share by Company (2017-2022)
Table 71. Europe Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 72. Europe Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 73. Europe Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 76. Europe Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 77. Europe Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 80. Europe Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 81. Europe Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Blood Glucose Device Sales by Company (2017-2022) & (K Units)
Table 84. Asia Pacific Blood Glucose Device Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Blood Glucose Device Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Blood Glucose Device Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 88. Asia Pacific Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 89. Asia Pacific Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 92. Asia Pacific Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 93. Asia Pacific Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Blood Glucose Device Sales by Region (2017-2022) & (K Units)
Table 96. Asia Pacific Blood Glucose Device Sales by Region (2023-2028) & (K Units)
Table 97. Asia Pacific Blood Glucose Device Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Blood Glucose Device Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Blood Glucose Device Sales by Company (2017-2022) & (K Units)
Table 100. Latin America Blood Glucose Device Sales Market Share by Company (2017-2022)
Table 101. Latin America Blood Glucose Device Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Blood Glucose Device Revenue Market Share by Company (2017-2022)
Table 103. Latin America Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 104. Latin America Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 105. Latin America Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 108. Latin America Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 109. Latin America Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 112. Latin America Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 113. Latin America Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Blood Glucose Device Sales by Company (2017-2022) & (K Units)
Table 116. Middle East and Africa Blood Glucose Device Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Blood Glucose Device Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Blood Glucose Device Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 120. Middle East and Africa Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 121. Middle East and Africa Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 124. Middle East and Africa Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 125. Middle East and Africa Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 128. Middle East and Africa Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 129. Middle East and Africa Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 131. Abbott Laboratories (U.S.) Corporation Information
Table 132. Abbott Laboratories (U.S.) Description and Overview
Table 133. Abbott Laboratories (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 134. Abbott Laboratories (U.S.) Blood Glucose Device Product and Services
Table 135. Abbott Laboratories (U.S.) Blood Glucose Device SWOT Analysis
Table 136. Abbott Laboratories (U.S.) Recent Developments
Table 137. ARKRAY (Japan) Corporation Information
Table 138. ARKRAY (Japan) Description and Overview
Table 139. ARKRAY (Japan) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 140. ARKRAY (Japan) Blood Glucose Device Product and Services
Table 141. ARKRAY (Japan) Blood Glucose Device SWOT Analysis
Table 142. ARKRAY (Japan) Recent Developments
Table 143. Dexcom (U.S.) Corporation Information
Table 144. Dexcom (U.S.) Description and Overview
Table 145. Dexcom (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 146. Dexcom (U.S.) Blood Glucose Device Product and Services
Table 147. Dexcom (U.S.) Blood Glucose Device SWOT Analysis
Table 148. Dexcom (U.S.) Recent Developments
Table 149. F.Hoffmann-La Roche Ltd (Switzerland) Corporation Information
Table 150. F.Hoffmann-La Roche Ltd (Switzerland) Description and Overview
Table 151. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 152. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product and Services
Table 153. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device SWOT Analysis
Table 154. F.Hoffmann-La Roche Ltd (Switzerland) Recent Developments
Table 155. Johnson & Johnson (U.S.) Corporation Information
Table 156. Johnson & Johnson (U.S.) Description and Overview
Table 157. Johnson & Johnson (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 158. Johnson & Johnson (U.S.) Blood Glucose Device Product and Services
Table 159. Johnson & Johnson (U.S.) Blood Glucose Device SWOT Analysis
Table 160. Johnson & Johnson (U.S.) Recent Developments
Table 161. Medtronic (U.S.) Corporation Information
Table 162. Medtronic (U.S.) Description and Overview
Table 163. Medtronic (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 164. Medtronic (U.S.) Blood Glucose Device Product and Services
Table 165. Medtronic (U.S.) Blood Glucose Device SWOT Analysis
Table 166. Medtronic (U.S.) Recent Developments
Table 167. Nipro Diagnostics (U.S.) Corporation Information
Table 168. Nipro Diagnostics (U.S.) Description and Overview
Table 169. Nipro Diagnostics (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 170. Nipro Diagnostics (U.S.) Blood Glucose Device Product and Services
Table 171. Nipro Diagnostics (U.S.) Blood Glucose Device SWOT Analysis
Table 172. Nipro Diagnostics (U.S.) Recent Developments
Table 173. Terumo Medical Corporation (U.S.) Corporation Information
Table 174. Terumo Medical Corporation (U.S.) Description and Overview
Table 175. Terumo Medical Corporation (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 176. Terumo Medical Corporation (U.S.) Blood Glucose Device Product and Services
Table 177. Terumo Medical Corporation (U.S.) Blood Glucose Device SWOT Analysis
Table 178. Terumo Medical Corporation (U.S.) Recent Developments
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Blood Glucose Device Distributors List
Table 182. Blood Glucose Device Customers List
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Glucose Device Product Picture
Figure 2. Global Blood Glucose Device Sales Market Share by Type in 2021 & 2028
Figure 3. Blood Glucose Monitors Product Picture
Figure 4. Glucose Monitoring Strips Product Picture
Figure 5. Lancets Product Picture
Figure 6. Global Blood Glucose Device Sales Market Share by Application in 2021 & 2028
Figure 7. Hospitals Use Case
Figure 8. Diagnostics Use Case
Figure 9. Home Settings Use Case
Figure 10. Others Use Case
Figure 11. Blood Glucose Device Report Years Considered
Figure 12. Global Blood Glucose Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Blood Glucose Device Market Size 2017-2028 (US$ Million)
Figure 14. Global Blood Glucose Device Sales (2017-2022) & (K Units)
Figure 15. Global Blood Glucose Device Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Blood Glucose Device Sales Market Share by Region (2017-2022)
Figure 17. Global Blood Glucose Device Sales Market Share by Region in 2021
Figure 18. Global Blood Glucose Device Revenue Market Share by Region in 2017 VS 2021
Figure 19. Global Blood Glucose Device Sales Share by Manufacturers in 2021
Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Blood Glucose Device Sales in 2021
Figure 21. Blood Glucose Device Revenue Share by Manufacturers in 2021
Figure 22. Blood Glucose Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global Blood Glucose Device Revenue Share by Type (2017-2022)
Figure 24. Global Blood Glucose Device Revenue Growth Rate by Type in 2017 & 2021
Figure 25. Global Blood Glucose Device Revenue Share by Application (2017-2022)
Figure 26. Global Blood Glucose Device Revenue Growth Rate by Application in 2017 & 2021
Figure 27. North America Blood Glucose Device Sales Market Share by Type (2017-2028)
Figure 28. North America Blood Glucose Device Revenue Market Share by Type (2017-2028)
Figure 29. North America Blood Glucose Device Sales Market Share by Application (2017-2028)
Figure
  • Global Non-Invasive Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 79
    This report studies The Non-Invasive Glucose Meter market. Noninvasive glucose monitoring refers to The measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from The disease) without drawing blood, puncturing The skin, or causing pain or trauma. The global Non-Invasive Glucose Meter market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 271.2 million by 2030, witnessing a CAGR of 6.0% during The......
  • Global Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 106
    Glucose Meter is a medical device for determining The approximate concentration of glucose in The blood. It can also be a strip of glucose paper dipped into a substance and measured to The glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking The skin with a lancet, is placed on a disposable test strip that The meter reads and uses to calculate The blood glucose level. The meter the......
  • Global Blood Glucose Testing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 101
    Blood glucose testing, also known as blood glucose monitoring, is one of The main tools involved in controlling diabetes. Blood glucose testing is The process used to measure The concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter. A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from The finger and applying it to a test strip that has been engaged into a blood gluc......
  • Global Glucose Biosensors Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Glucose Biosensors market size was valued at US$ 3249.7 million in 2023. With growing demand in downstream market, the Glucose Biosensors is forecast to a readjusted size of US$ 3620.7 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Glucose Biosensors market. Glucose Biosensors are expected to show stable growth in the future market. However, product ......
  • Global Artificial Pancreas Devices Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period. The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expect......
  • Global Blood Glucose Testing Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 130
    According to our LPI (LP Information) latest study, the global Blood Glucose Testing market size was valued at US$ 10710 million in 2023. With growing demand in downstream market, the Blood Glucose Testing is forecast to a readjusted size of US$ 13370 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Blood Glucose Testing market. Blood Glucose Testing are expected to show stable growth in the future market. However......
  • Global Lancing Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Lancing Devices market size was valued at US$ 315 million in 2023. With growing demand in downstream market, the Lancing Devices is forecast to a readjusted size of US$ 439.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Lancing Devices market. Lancing Devices are expected to show stable growth in the future market. However, product differentiation,......
  • Global Non-Invasive Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Meter market size was valued at US$ 175.6 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Meter is forecast to a readjusted size of US$ 268 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Non-Invasive Glucose Meter market. Non-Invasive Glucose Meter are expected to show stable growth in the futu......
  • Global Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Glucose Meter market size was valued at US$ 1258 million in 2023. With growing demand in downstream market, the Glucose Meter is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Glucose Meter market. Glucose Meter are expected to show stable growth in the future market. However, product differentiation, reduc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs